Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tomohiro Oba
Observed names:
Oba, Tomohiro,
T. Oba,
TOMOHIRO OBA
Institutions:
Dokkyo Medical University Saitama Medical Center,
Saitama Red Cross Hospital
Observed institutions:
SHOWA Medical University,
Dokkyo Medical University Saitama Medical Center,
Saitama Red Cross Hospital,
National Hospital Organization Saitama Hospital
ORCID:
0009-0004-1500-5215
Observed ORCID:
0009-0004-1500-5215
OpenAlex ID:
A5089295033
Works
101
Awards
1
Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria
2019
·
Hideaki Yamakawa
, Shintaro Sato
, et al.
·
Journal of Thoracic Disease
·
72
PDF
Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report
2019
·
Hideaki Yamakawa
, Tomohiro Oba
, et al.
·
BMC Pulmonary Medicine
·
37
Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease
2020
·
Hideaki Yamakawa
, Shintaro Sato
, et al.
·
BMC Pulmonary Medicine
·
33
PDF
Soluble intercellular adhesion molecule-1 for stable and acute phases of idiopathic pulmonary fibrosis
2015
·
Ryo Okuda
, Hidekazu Matsushima
, et al.
·
SpringerPlus
·
26
PDF
Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study)
2023
·
Atsushi Nakamura
, Ou Yamaguchi
, et al.
·
European Journal of Cancer
·
25
Body weight loss is a simple and useful indicator of prognosis and predictive tolerability in the first year of nintedanib therapy in patients with interstitial lung disease
2024
·
Hideaki Yamakawa
, Shintaro Sato
, et al.
·
Respiratory Investigation
·
20
The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease
2020
·
Hideaki Yamakawa
, Takashi Ogura
, et al.
·
Respiratory Medicine
·
19
Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report
2020
·
S. Sato
, K. Akasaka
, et al.
·
BMC Pulmonary Medicine
·
18
PDF
Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer
2023
·
Shinsuke Ogusu
, Yuhei Harutani
, et al.
·
Cancer Immunology Immunotherapy
·
16
PDF
Efficacy and safety of inhaled N-acetylcysteine in idiopathic pulmonary fibrosis: A prospective, single-arm study
2015
·
Ryo Okuda
, Hidekazu Matsushima
, et al.
·
Respiratory Investigation
·
15
Prognostic value of radiological findings indeterminate for UIP pattern and anterior upper lobe honeycomb-like lesion in chronic fibrosing interstitial lung disease associated with MPO-ANCA
2021
·
Hideaki Yamakawa
, Shintaro Sato
, et al.
·
BMC Pulmonary Medicine
·
13
PDF
Lenvatinib for patients with previously treated advanced thymic carcinoma in real-world settings
2025
·
K. Takagi
, G. Saito
, et al.
·
ESMO Open
·
11
PDF
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non–Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study
2024
·
Naoya Nishioka
, Tae Hata
, et al.
·
Cancer Research and Treatment
·
11
PDF
Patient background and prognosis of chronic pulmonary aspergillosis in fibrosing interstitial lung disease
2022
·
Hideaki Yamakawa
, Tomotaka Nishizawa
, et al.
·
Medicine
·
11
Exploration of clinical Biomarkers for guiding treatment selection between chemotherapy and combination therapy with Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Mutant NSCLC patients after EGFR-TKI Therapy: The SPIRAL-STEP study
2025
·
Kenji Morimoto
, Tadaaki Yamada
, et al.
·
Lung Cancer
·
10
PDF
Retrospective cohort study: a comparison of two different management strategies in patients with preterm premature rupture of membranes
2012
·
Azusa Shinjo
, Katsufumi Otsuki
, et al.
·
Archives of Gynecology and Obstetrics
·
9
Comparison of immune checkpoint inhibitor plus chemotherapy or ipilimumab plus nivolumab-based therapy for NSCLC patients with PD-L1 TPS (1–49 %): TOPGAN2023-01
2024
·
Hisashi Tanaka
, Tomonori Makiguchi
, et al.
·
European Journal of Cancer
·
8
PDF
Can transbronchial lung cryobiopsy benefit adaptive treatment strategies in connective tissue disease-associated interstitial lung disease?
2023
·
Hideaki Yamakawa
, Tamiko Takemura
, et al.
·
BMC Pulmonary Medicine
·
8
PDF
A case of anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease complicated with tracheobronchial ulcers
2018
·
Emiri Tsumiyama
, Hideaki Yamakawa
, et al.
·
Respiratory Medicine Case Reports
·
7
PDF
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan
2025
·
Shiho Goda
, Tadaaki Yamada
, et al.
·
Translational Lung Cancer Research
·
6
Nivolumab-induced contact dermatitis in a patient with advanced lung cancer
2020
·
Shintaro Sato
, Tomohiro Oba
, et al.
·
Respiratory Medicine Case Reports
·
6
PDF
Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025
·
Tae Hata
, Tadaaki Yamada
, et al.
·
Cancer Research Communications
·
5
PDF
Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax.
2022
·
Hideaki Yamakawa
, Yuta Tsukahara
, et al.
·
Sarcoidosis vasculitis and diffuse lung diseases
·
5
PDF
Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
2020
·
Shintaro Sato
, Tomohiro Oba
, et al.
·
Respiratory Medicine Case Reports
·
5
PDF
Utility of serum CYFRA 21-1 as a prognostic biomarker in ALK-positive non-small cell lung cancer treated with ALK-TKIs: a retrospective cohort study
2025
·
Ryo Sawada
, Tadaaki Yamada
, et al.
·
Translational Lung Cancer Research
·
4
Show more works
View as search
Works count:
101
Citation count:
448
H-index:
11
I10-index:
15
Year
Topic
Type